Genome wiz Venter partners with Roche in DNA sequencing deal

January 15, 2015 | Genome pioneer J. Craig Venter has signed a multi-year deal to sequence and analyze tens of thousands of genomes for Roche's Genentech unit in a deal aimed at identifying new drug targets. Reuters